Yongdong Jiang

914 citations
25 papers · 571 indexed · h-index 14
Topics
Fibroblast Growth Factor Research (5 papers)Estrogen and related hormone effects (4 papers)Breast Cancer Treatment Studies (4 papers)

In The Last Decade

Yongdong Jiang

24 papers receiving 566 citations

Peers

Yongdong Jiang
Comparison fields: 5 of 71
  • Molecular Biology 308
  • Cancer Research 189
  • Oncology 157
  • Immunology 107
  • Pathology and Forensic Medicine 95
Replace O. I. Olopade with:
O. I. Olopade United States
George S. Charames Canada
О. С. Ларін United States
R. Serafini Italy
Katie A. Ashton Australia
Małgorzata Nowicka Switzerland
Margaret H. Veldman-Jones United Kingdom
Kazushige Furuya Japan
Xiao Lv China
Cristina Mirantes Spain
Yongdong Jiang relative to O. I. Olopade United States O. I. Olopade's profile →
Citations per field
00.5×11.5×
O. I. Olopade · 1×
Citations per year

Countries citing papers authored by Yongdong Jiang

Since Specialization
Citations

This map shows the geographic impact of Yongdong Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongdong Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongdong Jiang more than expected).

Fields of papers citing papers by Yongdong Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongdong Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongdong Jiang. The network helps show where Yongdong Jiang may publish in the future.

Co-authorship network of co-authors of Yongdong Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yongdong Jiang. A scholar is included among the top collaborators of Yongdong Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongdong Jiang. Yongdong Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 15
3 20
4 27
5 13
6 1
7 11
8 38
9 15
10 75
11 22
12 10
13 5
14 92
15 42
16 49
17 18
18 45
19 28
20 5

About Yongdong Jiang

Yongdong Jiang is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 25 papers that have together received 571 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (5 papers), Estrogen and related hormone effects (4 papers) and Breast Cancer Treatment Studies (4 papers). The work is most often cited by research in Cancer Research (189 citations), Oncology (157 citations) and Pathology and Forensic Medicine (95 citations). Yongdong Jiang has collaborated with scholars based in China, United Kingdom and France. Frequent co-authors include Da Pang, Shanshan Sun, Xianyu Zhang, Lihong Wang, Youxue Zhang, Xiaoshuan Liang, Wei Jiang, Guoqiang Zhang, Zhihua Wang and Yue Yang. Their work appears in journals such as PLoS ONE, British Journal of Cancer and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026